296.03

1.59% -4.78

After Hours: 296.03

Medpace Holdings Inc (MEDP)

Overview News Price History Option Chain Financials Discussions Forecast

Medpace Holdings Inc stock is traded at $296.03, with a volume of 199.91K. It is down -1.59% in the last 24 hours and down -2.16% over the past month. Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Previous Close:

$300.81

Open:

$301.79

24h Volume:

199.91K

Relative Volume:

0.40

Market Cap:

$8.77B

Revenue:

$2.07B

Net Income/Loss:

$365.67M

P/E Ratio:

25.92

EPS:

11.42

Net Cash Flow:

$535.65M

1W Performance:

-2.98%

1M Performance:

-2.16%

6M Performance:

-18.40%

1Y Performance:

-25.84%

1-Day Range:

$295.92

$302.86

1-Week Range:

$284.10

$305.74

52-Week Range:

$250.05

$459.77

Medpace Holdings Inc Stock (MEDP) Company Profile

Name

Medpace Holdings Inc

Sector

Healthcare (1153)

Industry

Diagnostics & Research (56)

Phone

(513) 579-9911

Address

5375 MEDPACE WAY, CINCINNATI, OH

Employee

5,900

Twitter

@WorkatMedpace

Next Earnings Date

2025-04-21

Latest SEC Filings

MEDP's Discussions on Twitter

Compare MEDP with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MEDP Medpace Holdings Inc	296.03	8.77B	2.07B	365.67M	535.65M	11.42
TMO Thermo Fisher Scientific Inc	403.13	159.89B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	189.73	142.45B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	491.70	37.95B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	106.93	30.97B	6.53B	1.26B	1.31B	4.35
IQV Iqvia Holdings Inc	148.99	26.72B	15.50B	1.33B	2.16B	7.34

Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Apr-14-25	Downgrade	TD Cowen	Buy → Hold
Mar-24-25	Initiated	Leerink Partners	Market Perform
Oct-23-24	Downgrade	Robert W. Baird	Outperform → Neutral
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-27-24	Downgrade	UBS	Buy → Neutral
Sep-25-24	Downgrade	Jefferies	Buy → Hold
Aug-01-24	Initiated	Truist	Hold
May-29-24	Initiated	TD Cowen	Buy
May-28-24	Initiated	Mizuho	Buy
Apr-23-24	Upgrade	Jefferies	Hold → Buy
Mar-18-24	Initiated	Deutsche Bank	Hold
Feb-15-24	Upgrade	UBS	Neutral → Buy
Oct-24-23	Upgrade	Robert W. Baird	Neutral → Outperform
May-08-23	Upgrade	Guggenheim	Neutral → Buy
Oct-27-22	Upgrade	UBS	Sell → Neutral
Sep-07-22	Initiated	UBS	Sell
May-24-22	Initiated	Guggenheim	Neutral
Aug-05-21	Resumed	Credit Suisse	Outperform
Oct-02-20	Upgrade	Truist	Hold → Buy
Jun-08-20	Upgrade	Robert W. Baird	Underperform → Neutral
May-13-20	Downgrade	Wolfe Research	Outperform → Peer Perform
Apr-30-20	Upgrade	SunTrust	Sell → Hold
Apr-20-20	Downgrade	Robert W. Baird	Neutral → Underperform
Mar-17-20	Downgrade	SunTrust	Hold → Sell
Jan-27-20	Downgrade	SunTrust	Buy → Hold
Oct-31-18	Upgrade	SunTrust	Hold → Buy
Sep-17-18	Initiated	SunTrust	Hold
Jul-31-18	Upgrade	William Blair	Mkt Perform → Outperform
Nov-01-17	Downgrade	William Blair	Outperform → Mkt Perform
Sep-29-17	Initiated	Raymond James	Mkt Perform
Jul-10-17	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight

View All

Medpace Holdings Inc Stock (MEDP) Latest News

May 09, 2025

MEDP STOCK ALERT: Levi & Korsinsky Notifies Medpace Holdings, Inc. Investors of an Ongoing Investigation - ACCESS Newswire

May 09, 2025

When Should You Buy Medpace Holdings, Inc. (NASDAQ:MEDP)? - Yahoo Finance

May 09, 2025

Medpace Holdings, Inc. to Host Earnings Call - ACCESS Newswire

May 09, 2025

May 08, 2025

Investor Optimism Abounds Medpace Holdings, Inc. (NASDAQ:MEDP) But Growth Is Lacking - simplywall.st

May 08, 2025

Apr 29, 2025

Medpace forecasts 2025 revenue between $2.14B and $2.24B amid funding challenges - MSN

Apr 29, 2025

Apr 28, 2025

Positive Long-Term Outlook for Narrow-Moat Medpace Despite Macroeconomic Pressure in Near Term - Morningstar

Apr 28, 2025

Apr 27, 2025

Truist Adjusts Medpace (MEDP) Price Target to $300, Maintains Hold Rating | MEDP Stock News - GuruFocus

Apr 23, 2025

Truist Cuts Price Target on Medpace Holdings to $300 From $333, Keeps Hold Rating - marketscreener.com

Apr 23, 2025

Medpace (MEDP) Price Target Reduced to $313 Amid Cautious Outloo - GuruFocus

Apr 23, 2025

Medpace Holdings First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Apr 23, 2025

Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st

Apr 23, 2025